)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Jointown Pharmaceutical Group
Jointown Pharmaceutical Group (600998) investor relations material
Jointown Pharmaceutical Group Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary28 Apr, 2026
Executive summary
Achieved record annual revenue of ¥161.39 billion, up 6.31% year-over-year, outpacing industry growth.
Operating cash flow improved 11.62% to ¥3.44 billion; adjusted net profit (excluding credit impairment) rose 9.13% year-over-year.
Completed strategic acquisition of Aoyuan Beauty Valley, expanding into medical aesthetics.
Upgraded credit rating to AAA, the only private AAA-rated company in the sector, reducing financing costs.
Maintained robust corporate governance, with six consecutive years of top-tier information disclosure ratings.
Financial highlights
Revenue: ¥161.39 billion, up 6.31% year-over-year.
Net profit attributable to shareholders: ¥2.25 billion, down 10.07% year-over-year due to increased credit impairment and lower non-recurring gains.
Adjusted net profit (excluding credit impairment): ¥1.98 billion, up 9.13% year-over-year.
Operating cash flow: ¥3.44 billion, up 11.62% year-over-year.
Gross margin: 7.75%; basic EPS: ¥0.44.
Proposed cash dividend: ¥0.20 per share, total payout ¥997 million, 44.23% payout ratio.
Outlook and guidance
Launched new three-year “Four New, Two Transformations” strategy (2026–2028): new products, new retail, new medical, new services, digitalization, capitalization.
Targeting over 45,000 retail outlets and 10,000 clinic alliances within three years.
Focus on AI-driven digital transformation, supply chain innovation, and capital market initiatives.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jointown Pharmaceutical Group
- Adjusted net profit rose 7.12% on 6.58% revenue growth, but reported profit fell due to lower one-time gains.600998
Q1 202628 Apr 2026 - Net profit surged 80.38% in Q1 2025, driven by a major REITs transaction gain.600998Q1 202522 Dec 2025
- Adjusted net profit up 9.5% year-over-year; Q2 profit and cash flow improved sequentially.600998Q2 202419 Dec 2025
- Net profit grew 15.33% to ¥2.51B, with strong cash flow and major REITs issuance.600998Q4 202419 Dec 2025
- Net profit rose 19.70% on 5.10% revenue growth, with strong digital and retail expansion.600998Q2 202519 Dec 2025
- Q3 2025 delivered solid profit growth, digital expansion, and a successful REITs listing.600998Q3 202528 Oct 2025
- Q3 saw resumed growth in revenue and profit, with digital and REITs strategies advancing.600998Q3 202413 Jun 2025
Jointown Pharmaceutical Group
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage